Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 26;19(5):2735.
doi: 10.3390/ijerph19052735.

Association between Green Tea Consumption and Abdominal Obesity Risk in Middle-Aged Korean Population: Findings from the Korean Genome and Epidemiology Study

Junkyung Kwak  1 , Dayeon Shin  1
Affiliations

Association between Green Tea Consumption and Abdominal Obesity Risk in Middle-Aged Korean Population: Findings from the Korean Genome and Epidemiology Study

Junkyung Kwak et al. Int J Environ Res Public Health. .

Abstract

The prevalence of general and abdominal obesity is increasing with rapid economic growth and the westernization of dietary habits in Korea, especially in the middle-aged population. Data were obtained from the Korean Genome and Epidemiology Study (KoGES), which recruited 10,030 participants between the ages of 40 and 69 years. Information on green tea consumption was obtained from the food frequency questionnaire and categorized as none, <1 cup, between 1 and <4 cups, and ≥4 cups. Multivariable logistic regression models were used to estimate the ORs and 95% CIs to examine any possible associations between green tea consumption and the risk of abdominal obesity after controlling for potential confounders. High consumption of green tea was associated with a 44% lower odds ratio for abdominal obesity (none vs. ≥4 cups/week: OR, 0.56; 95% CI 0.41-0.78; p for trend = 0.001). When stratified by sex, an inverse association between green tea consumption and abdominal obesity was observed only in women (none vs. ≥4 cups/week: OR, 0.71; 95% CI 0.57−0.88; p for trend = 0.004). No significant association was found among men. Our findings indicate that green tea consumption has beneficial effects in the prevention of abdominal obesity in middle-aged Korean women.

Keywords: Korean Genome and Epidemiology Study (KoGES); abdominal obesity; green tea consumption; metabolic syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Process flow chart outlining the relevant steps for this analysis.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Ritchie S., Connell J. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr. Metab. Cardiovasc. Dis. 2007;17:319–326. doi: 10.1016/j.numecd.2006.07.005. - DOI - PubMed
    1. National Health Insurance Service . National Health Screening Statistical Yearbook 2019. National Health Insurance Service; Wonju, Gangwon-do, Korea: 2019. [(accessed on 2 March 2021)]. Available online: https://www.nhis.or.kr/nhis/together/wbhaec07000m01.do?mode=view&article....
    1. Dagenais G.R., Yi Q., Mann J.F., Bosch J., Pogue J., Yusuf S., HOPE Study Investigators Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. Am. Heart J. 2005;149:54–60. doi: 10.1016/j.ahj.2004.07.009. - DOI - PubMed
    1. Postorino M., Marino C., Tripepi G., Zoccali C., CREDIT Working Group Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J. Am. Coll. Cardiol. 2009;53:1265–1272. doi: 10.1016/j.jacc.2008.12.040. - DOI - PubMed
    1. Pischon T., Boeing H., Hoffmann K., Bergmann M., Schulze M.B., Overvad K., Van der Schouw Y., Spencer E., Moons K., Tjønneland A. General and abdominal adiposity and risk of death in Europe. N. Engl. J. Med. 2008;359:2105–2120. doi: 10.1056/NEJMoa0801891. - DOI - PubMed

LinkOut - more resources